Rossari Biotech Limited — Board Meeting, 19-07-2025: Outcome of Board Meeting

Rossari Biotech's board met and approved the financial results for the quarter. The company reported consolidated revenue of Rs. 543.72 Cr and a profit after tax of Rs. 33.60 Cr. The board also cleared the allotment of 375 equity shares at Rs. 2 each, following the exercise of employee stock options under ESOP 2019, priced at Rs. 425 per share. This issuance increases the paid-up equity capital to Rs. 11.07 Cr. This move reflects continued employee participation in the company's growth story.